| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |